HUP0303729A3 - Novel heteroaryl derivatives and the use thereof as pharmaceuticals and process for their preparation - Google Patents

Novel heteroaryl derivatives and the use thereof as pharmaceuticals and process for their preparation

Info

Publication number
HUP0303729A3
HUP0303729A3 HU0303729A HUP0303729A HUP0303729A3 HU P0303729 A3 HUP0303729 A3 HU P0303729A3 HU 0303729 A HU0303729 A HU 0303729A HU P0303729 A HUP0303729 A HU P0303729A HU P0303729 A3 HUP0303729 A3 HU P0303729A3
Authority
HU
Hungary
Prior art keywords
pharmaceuticals
preparation
heteroaryl derivatives
novel heteroaryl
novel
Prior art date
Application number
HU0303729A
Other languages
English (en)
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of HUP0303729A2 publication Critical patent/HUP0303729A2/hu
Publication of HUP0303729A3 publication Critical patent/HUP0303729A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0303729A 2000-07-21 2001-07-18 Novel heteroaryl derivatives and the use thereof as pharmaceuticals and process for their preparation HUP0303729A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035927A DE10035927A1 (de) 2000-07-21 2000-07-21 Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
PCT/EP2001/008263 WO2002008194A1 (de) 2000-07-21 2001-07-18 Acridin-derivate und deren verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
HUP0303729A2 HUP0303729A2 (hu) 2004-03-01
HUP0303729A3 true HUP0303729A3 (en) 2009-01-28

Family

ID=7649979

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303729A HUP0303729A3 (en) 2000-07-21 2001-07-18 Novel heteroaryl derivatives and the use thereof as pharmaceuticals and process for their preparation

Country Status (29)

Country Link
US (1) US6706722B2 (hu)
EP (1) EP1301485B1 (hu)
JP (1) JP2004504382A (hu)
KR (1) KR20030022296A (hu)
CN (1) CN1296359C (hu)
AR (1) AR033383A1 (hu)
AT (1) ATE365717T1 (hu)
AU (2) AU8967501A (hu)
BG (1) BG107507A (hu)
BR (1) BR0112591A (hu)
CA (1) CA2353360A1 (hu)
CY (1) CY1106890T1 (hu)
CZ (1) CZ2003427A3 (hu)
DE (2) DE10035927A1 (hu)
DK (1) DK1301485T3 (hu)
ES (1) ES2291349T3 (hu)
HK (1) HK1057549A1 (hu)
HU (1) HUP0303729A3 (hu)
IL (1) IL153476A0 (hu)
MX (1) MXPA02012564A (hu)
NO (1) NO324939B1 (hu)
NZ (1) NZ524155A (hu)
PL (1) PL358808A1 (hu)
PT (1) PT1301485E (hu)
RU (1) RU2267488C2 (hu)
SK (1) SK1932003A3 (hu)
UA (1) UA75085C2 (hu)
WO (1) WO2002008194A1 (hu)
ZA (1) ZA200210411B (hu)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035928A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
NZ537916A (en) * 2002-06-29 2005-11-25 Zentaris Gmbh Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant diseases
AU2003232785A1 (en) * 2002-07-17 2004-02-02 Zentaris Gmbh Novel anthracene derivatives and the use thereof as a medicament
US7125461B2 (en) * 2003-05-07 2006-10-24 L & L Products, Inc. Activatable material for sealing, baffling or reinforcing and method of forming same
AR044586A1 (es) * 2003-06-04 2005-09-21 Aventis Pharma Sa Productos aril - heteroaromaticos, composiciones que los contienen y su utilizacion
FR2855825B1 (fr) * 2003-06-04 2008-08-22 Aventis Pharma Sa Produits aryl-heteroaromatiques, compositions les contenant et utilisation
US7249415B2 (en) * 2003-06-26 2007-07-31 Zephyros, Inc. Method of forming members for sealing or baffling
DE10331500A1 (de) * 2003-07-11 2005-02-24 Zentaris Gmbh Neue Acridin-Derivate und deren Verwendung als Arzneimittel
WO2006080043A2 (en) * 2005-01-27 2006-08-03 Alma Mater Studiorum- Universita' Di Bologna Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
US20070299093A1 (en) * 2005-01-27 2007-12-27 Alma Mater Studiorum-Universitá Di Bologna Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation
EP2125750B1 (en) * 2007-02-26 2014-05-21 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
ATE554078T1 (de) * 2007-07-26 2012-05-15 Vitae Pharmaceuticals Inc Synthese von 11-beta-hydroxysteroid-dehydrogenase-1-hemmern
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
WO2009075835A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
US8592409B2 (en) * 2008-01-24 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5734666B2 (ja) * 2008-02-11 2015-06-17 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の１，３−オキサアゼパン−２−オン及び１，３−ジアゼパン−２−オン阻害剤
JP5730021B2 (ja) * 2008-02-15 2015-06-03 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の阻害剤としてのシクロアルキルラクタム誘導体
JP5538356B2 (ja) * 2008-03-18 2014-07-02 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤
AR071609A1 (es) * 2008-05-01 2010-06-30 Vitae Pharmaceuticals Inc Inhibidores ciclicos de 11(beta) -hidroxiesteroide deshidrogenasa 1
AR071236A1 (es) 2008-05-01 2010-06-02 Vitae Pharmaceuticals Inc Inhibidores ciclicos de la 11beta-hidroxiesteroide deshidrogenasa 1
EP2291370B1 (en) 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723032A1 (en) * 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2730499A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2010010157A2 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
EP2393807B1 (en) 2009-02-04 2013-08-14 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
US20100331320A1 (en) * 2009-04-30 2010-12-30 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2440537A1 (en) 2009-06-11 2012-04-18 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
US8883778B2 (en) 2009-07-01 2014-11-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
EP2585444B1 (en) 2010-06-25 2014-10-22 Boehringer Ingelheim International GmbH Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
WO2012059416A1 (en) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2538388B1 (fr) 1982-12-24 1985-06-21 Pharmuka Lab Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
US5030631A (en) * 1989-11-27 1991-07-09 Schering Corporation Tricylclic arylsulfonamides
US6028195A (en) * 1996-06-29 2000-02-22 Samjin Pharmaceutical Co., Ltd. Piperazine derivatives and process for the preparation thereof
US5861395A (en) 1996-09-13 1999-01-19 Schering Corporation Compounds useful for inhibition of farnesyl proteins transferase
FR2753706B1 (fr) 1996-09-20 1998-10-30 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant
DE19743435A1 (de) 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
CN1261098C (zh) 1998-08-28 2006-06-28 西奥斯股份有限公司 p38－α激酶的抑制剂
JP2002538121A (ja) 1999-03-03 2002-11-12 メルク エンド カムパニー インコーポレーテッド プレニルタンパク質トランスフェラーゼの阻害剤

Also Published As

Publication number Publication date
CN1443172A (zh) 2003-09-17
NZ524155A (en) 2005-04-29
DK1301485T3 (da) 2007-11-05
WO2002008194A1 (de) 2002-01-31
RU2267488C2 (ru) 2006-01-10
ES2291349T3 (es) 2008-03-01
UA75085C2 (en) 2006-03-15
NO20030301L (no) 2003-03-11
CN1296359C (zh) 2007-01-24
US6706722B2 (en) 2004-03-16
AU2001289675B2 (en) 2005-04-07
MXPA02012564A (es) 2003-09-22
ATE365717T1 (de) 2007-07-15
DE50112669D1 (de) 2007-08-09
HK1057549A1 (en) 2004-04-08
PT1301485E (pt) 2007-08-30
HUP0303729A2 (hu) 2004-03-01
IL153476A0 (en) 2003-07-06
ZA200210411B (en) 2003-02-26
WO2002008194A8 (de) 2003-05-08
KR20030022296A (ko) 2003-03-15
EP1301485A1 (de) 2003-04-16
CZ2003427A3 (cs) 2003-06-18
BG107507A (bg) 2003-09-30
JP2004504382A (ja) 2004-02-12
SK1932003A3 (en) 2003-10-07
DE10035927A1 (de) 2002-03-07
NO324939B1 (no) 2008-01-07
CA2353360A1 (en) 2002-01-21
US20020132821A1 (en) 2002-09-19
EP1301485B1 (de) 2007-06-27
PL358808A1 (en) 2004-08-23
AU8967501A (en) 2002-02-05
NO20030301D0 (no) 2003-01-20
AR033383A1 (es) 2003-12-17
CY1106890T1 (el) 2012-09-26
BR0112591A (pt) 2003-07-22

Similar Documents

Publication Publication Date Title
HUP0303729A3 (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals and process for their preparation
IL153361A0 (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals
AU2001289675A1 (en) Novel Heteroaryl Derivatives and the Use Thereof as Pharmaceuticals
AU2001279757A1 (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals
AU8198901A (en) Novel heteroaryl derivatives and use thereof as medicaments
HUP0204245A3 (en) Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0300616A3 (en) Adamantane derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0203766A3 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
IL161431A0 (en) beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
PL350190A1 (en) Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
HUP0201730A3 (en) Thienopyrimidines as phosphodiesterase inhibitors, their use, pharmaceutical compositions containing them and process for the preparation thereof
HUP0303105A3 (en) Novel aminocyclohexane derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203859A3 (en) Aminomethyl-phenyl-cyclohexanone derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
IL149993A0 (en) Novel heteroaryl derivatives, their preparation and use
EP1556364A4 (en) ISOTHIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THESE DERIVATIVES
HUP0303110A3 (en) 5-amino-1-pentene-3-ol substituted derivatives, process for their preparation and pharmaceutical compositions containing them and their use
IL156861A0 (en) Pyrrole derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
IL160606A0 (en) C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
AU2001260083A1 (en) New pharmaceutical composition and the process for its preparation
IL160608A0 (en) C2-substituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
SI1301485T1 (sl) Derivati akridina in njihova uporaba kot zdravila
IL160938A0 (en) Coniosulphides and their derivatives, processes for preparing them, and their use as pharmaceuticals
IL151216A0 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ZENTARIS GMBH, DE

Free format text: FORMER OWNER(S): ZENTARIS AG, DE; ZENTARIS GMBH, DE

FD9A Lapse of provisional protection due to non-payment of fees